Transcriptional and Cytokine Profiles Identify CXCL9 as a Biomarker of Disease Activity in Morphea
Jack C. O’BrienUniversity of Texas Southwestern Medical Center, Department of Dermatology, Dallas, Texas, USAYevgeniya RainwaterUniversity of Texas Southwestern Medical Center, Department of Dermatology, Dallas, Texas, USANeeta MalviyaUniversity of Texas Southwestern Medical Center, Department of Dermatology, Dallas, Texas, USANika CyrusUniversity of Texas Southwestern Medical Center, Department of Dermatology, Dallas, Texas, USALorenz Auer‐HackenbergUniversity of Texas Southwestern Medical Center, Department of Dermatology, Dallas, Texas, USALinda S. HynanUniversity of Texas Southwestern Medical Center, Department of Clinical Sciences, Dallas, Texas, USAGregory A. HoslerUniversity of Texas Southwestern Medical Center, Department of Dermatology, Dallas, Texas, USA; ProPath, Dallas, Texas, USAHeidi JacobeUniversity of Texas Southwestern Medical Center, Department of Dermatology, Dallas, Texas, USA. Electronic address: [email protected]
2017en
ABI
Аннотация
Аннотация мавжуд эмас.
Идентификаторлар
Иқтибослар ва манбалар
2 та иқтибос0 та фойдаланилган манба